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Since the discovery of the phosphorylation of the 40S ribosomal protein S6 (rpS6)
about four decades ago, much effort has been made to uncover the molecular
mechanisms underlying the regulation of this post-translational modification. In the field
of neuroscience, rpS6 phosphorylation is commonly used as a readout of the mammalian
target of rapamycin complex 1 signaling activation or as a marker for neuronal activity.
Nevertheless, its biological role in neurons still remains puzzling. Here we review the
pharmacological and physiological stimuli regulating this modification in the nervous
system as well as the pathways that transduce these signals into rpS6 phosphorylation.
Altered rpS6 phosphorylation observed in various genetic and pathophysiological mouse
models is also discussed. Finally, we examine the current state of knowledge on the
physiological role of this post-translational modification and highlight the questions that
remain to be addressed.
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INTRODUCTION
The eukaryotic ribosome is composed of the small 40S and the large 60S subunits,
comprising together 4 ribosomal RNA species and 79 ribosomal proteins (Kressler et al.,
2010). In many organisms, ribosomal proteins undergo various post-translational modifications,
including phosphorylation, acetylation, methylation, O-linked β-N-acetylglucosaminylation, and
ubiquitylation (Xue and Barna, 2012). Historically, the phosphorylation of the 40S ribosomal
protein S6 (rpS6) was the first post-translational modification described (Gressner and Wool,
1974). The presence of phospho-rpS6 (p-rpS6) at different levels in a 2D gel provided the first
evidence that rpS6 phosphorylation could occur at several residues (Lastick et al., 1977). Ensuing
studies identified five evolutionary conserved and clustered carboxy-terminal phospho-sites, which
undergo phosphorylation in an ordered manner, beginning with Ser236 and followed sequentially
by Ser235, Ser240, Ser244, and Ser247 (Martin-Pérez and Thomas, 1983; Wettenhall et al., 1992;
Meyuhas, 2008, 2015). Intriguingly, the exact function of the post-translational modification of
this indispensable ribosomal protein remains enigmatic. Despite the large debate regarding its
physiological role, rpS6 phosphorylation is commonly used as a marker for neuronal activity and a
readout of mammalian target of rapamycin complex 1 (mTORC1) activity (Meyuhas, 2008, 2015;
Mahoney et al., 2009; Knight et al., 2012). This review summarizes our current knowledge regarding
the molecular mechanisms as well as the variety of stimuli modulating rpS6 phosphorylation in the
nervous system.
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REGULATION OF rpS6
PHOSPHORYLATION
The p70/p85 S6 kinase 1 (S6K1), which is able to catalyze
the phosphorylation of rpS6 at all sites, was the first kinase
identified (Krieg et al., 1988; Ferrari et al., 1991; Bandi et al.,
1993; Meyuhas, 2008, 2015). Further studies described additional
protein kinases targeting selectively the Ser235 and Ser236
residues. These include p90 Ribosomal S6 Kinases (RSK1-4)
(Roux et al., 2007), Protein Kinase C (House et al., 1987),
Protein Kinase A (PKA) (Moore et al., 2009; Valjent et al.,
2011; Yano et al., 2014; Biever et al., 2015), Protein Kinase
G (Yano et al., 2014), and Death-Associated Protein Kinase
(DAPK) (Schumacher et al., 2006) (Figure 1). Although less
studied, the residue Ser247 has been identified as a target
of Casein Kinase 1 (Hutchinson et al., 2011). Contrasting
with the diversity of kinases regulating rpS6 phosphorylation,
the dephosphorylation of the five residues is achieved by a
single phosphatase: the Protein Phosphatase-1 (PP-1) (Belandia
et al., 1994; Hutchinson et al., 2011) (Figure 1). Since the
molecular mechanisms regulating rpS6 phosphorylation have
been recently extensively reviewed (Meyuhas, 2015), we focus on
the contribution of S6K1/2 kinases and the PKA/PP-1 pathway,
being the main upstream mechanisms described to regulate rpS6
phosphorylation in the nervous system.
S6K1/2 Pathway
In mammalian cells, two different genes encode two isoforms
of the S6 Kinase, S6K1, and S6K2. S6K1 has cytosolic and
nuclear isoforms (p70 S6K1 and p85 S6K1, respectively), whereas
both S6K2 isoforms (p54 S6K2 and p56 S6K2) are primarily
nuclear (Martin et al., 2001). As demonstrated by the use of
S6K1/S6K2 double knockout mice, both isoforms contribute to
the regulation of basal and inducible rpS6 phosphorylation at
S235/236 and S240/244 sites (Pende et al., 2004; Kroczynska et al.,
2009; Chauvin et al., 2014). Different observations were made in
FIGURE 1 | rpS6 phosphorylatable residues are targeted by multiple
kinases and dephosphorylated by PP-1. Mus musculus sequence of the
C-terminal domain of rpS6 depicting the 5 phosphorylatable sites and their
respective kinases. S6K catalyzes the phosphorylation of all the residues, while
PKA, RSK, PKC, PKG, and DAPK target the S235 and S236 sites. CK1
selectively phosphorylates the S247 residue. All phospho-sites are
dephosphorylated by PP-1. See text for details.
single S6K knockout mice. Indeed, while the S6K2 knockout mice
display a reduction of rpS6 phosphorylation only at S235/236
sites in the hippocampus (Antion et al., 2008a), S6K1-deficient
mice show no alterations (Antion et al., 2008a; Bhattacharya
et al., 2012). Compensatorymechanisms taking place in the single
knockout mice could explain these latter observations since viral-
mediated overexpression of a constitutive-active S6K1 (S6K1CA)
or kinase-inactive S6K1 (S6K1 KI) in the medial prefrontal cortex
increases or decreases basal rpS6 phosphorylation, respectively
(Dwyer et al., 2015). Pharmacological evidences also support the
critical role of S6K in the regulation of rpS6 phosphorylation.
S6K1/2 undergo phosphorylation at 8 Ser/Thr phospho-sites,
including 4 serine residues in the C-terminal autoinhibitory
domain. Phosphorylation of the autoinhibitory domain was
originally proposed to trigger a more relaxed conformation of
the protein allowing its phosphorylation at T389 by mTORC1
leading to S6K activation (Dennis et al., 1998). Thus, the
blockade of canonical mTORC1/S6K signaling by the mTORC1
inhibitor rapamycin suppresses both basal and stimuli-induced
rpS6 phosphorylation in various brain areas (Kelleher et al., 2004;
Takei et al., 2004; Cota et al., 2006; Antion et al., 2008a; Gobert
et al., 2008; Géranton et al., 2009; Santini et al., 2009; Zeng et al.,
2009; Huang et al., 2010; Cao et al., 2011; Troca-Marín et al.,
2011; Wu et al., 2011; Bailey et al., 2012; Bertran-Gonzalez et al.,
2012; Meffre et al., 2012; Brewster et al., 2013; Macias et al., 2013;
Bowling et al., 2014; Biever et al., 2015).
Although the activation of S6K and the subsequent
phosphorylation of rpS6 are commonly used as a readout
of mTORC1 activation, several evidences point out the
existence of a synergistic crosstalk between mTORC1 and
the extracellular signal-regulated kinase (ERK) signaling to
control rpS6 phosphorylation. Thus, ERK can promote S6K
activation by enhancing its phosphorylation at T421/S424 sites
(Mukhopadhyay et al., 1992). When phosphorylated, these sites
located in the autoinhibitory domain of the S6K1/2 are thought
to prime the activation of S6K, thereby facilitating the subsequent
phosphorylation of the other sites of S6K by the upstream kinases
(Dennis et al., 1998). Alternatively, ERK can also modulate the
mTORC1/S6K cascade upstream of S6K. On the one hand,
ERK-mediated inhibitory phosphorylation of Tuberous Sclerosis
Complex 2 (TSC2) stimulates the Ras Homolog Enriched in
Brain (Rheb) protein, which in turn activates mTORC1 (Roux
and Blenis, 2004; Long et al., 2005; Ma et al., 2005). On the
other hand, ERK can enhance mTORC1 activation through
RSK-mediated phosphorylation of Raptor (Wettenhall et al.,
1992). Examples of this synergistic interaction between ERK
and mTORC1 in the regulation of rpS6 phosphorylation have
been reported in several models and in various brain areas
(Kelleher et al., 2004; Antion et al., 2008a; Gobert et al., 2008;
Santini et al., 2009; Gangarossa et al., 2014) Interestingly, ERK
can also regulate rpS6 phosphorylation at S235/236 through
RSK independently of mTORC1/S6K signaling (Roux et al.,
2007). Indeed, the increase in pS235/236-rpS6 promoted by
tetraethylammonium in cultured cortical neurons is prevented
by RSK3 inhibition (Gu et al., 2015). Finally, a recent study
performed in hippocampal neurons demonstrated that the
cdk5-dependent phosphorylation of S6K at S411 site is also
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critical in the regulation of S6K activation and the subsequent
rpS6 phosphorylation at S235/236 sites (Lai et al., 2015).
cAMP/PKA Pathway
The enhanced rpS6 phosphorylation in the cerebral cortex
following the administration of N6O-2′dibutyryl cAMP was
one of the first demonstrations that cAMP could modulate
in vivo the state of phosphorylation of rpS6 (Roberts and
Morelos, 1979). Despite this evidence, the contribution of the
cAMP/PKA pathway in the regulation of rpS6 phosphorylation
in the nervous system has been largely neglected. However, recent
studies highlighted the importance of cAMP/PKA signaling in
the regulation of rpS6 phosphorylation at S235/236 sites. Thus,
the direct stimulation of the adenylate cyclase by forskolin
increases pS235/236-rpS6 in the striatum and the hippocampus
(Gobert et al., 2008; Biever et al., 2015) (Table 1). Similar
results are obtained when the degradation of cAMP is prevented
by the administration of papaverine, a potent inhibitor of
type 10A phosphodiesterase (Biever et al., 2015). Although the
demonstration that PKA directly catalyzes rpS6 phosphorylation
in the brain is still lacking, several indirect evidences support its
contribution in the control of pS235/236-rpS6 following cAMP
elevation. Indeed, forskolin-induced rpS6 phosphorylation in
striatal slices is reduced in the presence of a PKA inhibitor
(Biever et al., 2015). Moreover, stimulation of PKA activity with
the cAMP analog cBIMPS increases pS235/236-rpS6 in striatal
culture (Valjent et al., 2011) (Table 1). Finally, the administration
of pharmacological agents promoting PKA activation triggers
rpS6 phosphorylation in several brain areas (Gobert et al., 2008;
Valjent et al., 2011; Knight et al., 2012; Bonito-Oliva et al., 2013;
Rapanelli et al., 2014; Biever et al., 2015; Sutton and Caron, 2015).
Although PKA targets selectively S235/236 residues
(Moore et al., 2009), recent evidences suggest that PKA
also contributes indirectly to rpS6 phosphorylation through
a protein phosphatase cascade. This mechanism has been
particularly well-studied in the striatum, where the inhibition
of PP-1, controlled by the PKA-dependent phosphorylation of
dopamine- and cAMP-regulated phosphoprotein, Mr 32,000
(DARPP-32) at T34 (Hemmings et al., 1984; Greengard, 2001),
promotes pS235/236-rpS6 induced by d-amphetamine or
haloperidol (Valjent et al., 2011; Bonito-Oliva et al., 2013; Biever
et al., 2015). This mechanism also contributes to the regulation
of rpS6 phosphorylation at S240/244 sites (Bonito-Oliva et al.,
2013). These findings highlight the importance of PKA/DARPP-
32/PP-1 signaling in the regulation of rpS6 phosphorylation
in the striatum and raise the intriguing hypothesis that similar
mechanisms could take place in other brain areas.
STIMULI MODULATING rpS6
PHOSPHORYLATION IN THE BRAIN
Recently an increasing number of studies have used rpS6
phosphorylation as a marker for neuronal activation in the
context of synaptic plasticity or in response to variety of
therapeutic agents in physiological and pathophysiological
contexts.
TABLE 1 | Pharmacological stimuli modulating rpS6 phosphorylation ex vivo.
Brain areas Model Treatment S235/236 S240/244 References
WHOLE BRAIN
Culture Insulin ↑ (NS) ↑ (NS) Heidenreich and Toledo, 1989
HIPPOCAMPUS
Culture BDNF ↑ ND Kelleher et al., 2004; Troca-Marín et al., 2011
Bicuculline ↑ ND Kelleher et al., 2004
Slice DHPG ↑ ↑ Antion et al., 2008a
Forskolin ↑ ND Gobert et al., 2008
STRIATUM
Culture cBIMPS ↑ ND Valjent et al., 2011
Haloperidol ND ↑ Bowling et al., 2014
Slice Forskolin ↑ ND Biever et al., 2015
6-OHDA/SKF81297 ↑ ↑ Santini et al., 2009
CORTEX
Synaptoneurosomes BDNF ND ↑ Takei et al., 2004
Culture Leucine ND ↑ Ishizuka et al., 2008
Bicuculline/glycine ↑ ND Lai et al., 2012
Tetraethylammonium ↑ ND Gu et al., 2015
BDNF ND ↑ Lenz and Avruch, 2005
GNA ND ↑ Lenz and Avruch, 2005
Glutamate/NMDA ND ↓ Lenz and Avruch, 2005
Bicuculline/4-AP ND ↑ Lenz and Avruch, 2005
NS, not specified; ND, not determined; GNA, Glutamate + NMDA followed 5 s later by the NMDA antagonist APV; 4-AP, 4-aminopyridine.
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TABLE 2 | Pharmacological stimuli modulating rpS6 phosphorylation in vivo.
Brain
areas
Model Treatment Doses (mg/kg) S235/236 S240/244 Cell-Type References
HIPPOCAMPUS
Mouse SKF81297 5 ↑ = Granule cells DG Gangarossa et al., 2011; Gangarossa and
Valjent, 2012
5* ↑ ↑ Granule cells DG Gangarossa et al., 2014
Kainate 12.5 ND ↑ Principal cells Knight et al., 2012
THC 10 ↑ ND Pyramidal cells Puighermanal et al., 2009
Rat Kainate 10 ↑ ND Pyramidal cells Macias et al., 2013
12 ↑ (NS) ↑ (NS) ND Zeng et al., 2009
ND ↑ ND Chen et al., 2012
Pilocarpine 300 ↑ (NS) ↑ (NS) ND Huang et al., 2010
PTZ 75 ↑ ↑ ND Zhang and Wong, 2012
STRIATUM
Mouse Cocaine 30 ND ↑ MSNs Knight et al., 2012
D-amphetamine 5 ↑ = ND Rapanelli et al., 2014
10 ↑ = D1-MSNs Biever et al., 2015
10* ↑ = ND Biever et al., 2015
Haloperidol 0.5 ↑ ↑ D2-MSNs Valjent et al., 2011; Bonito-Oliva et al.,
2013
Clozapine 5 ↑ ↑ D2-MSNs Valjent et al., 2011
Papaverine 30 ↑ ↑ D1- and D2-MSNs Biever et al., 2015
SKF81297 5 ↑ ND D1-MSNs Gangarossa et al., 2013
Quinpirole 1 ↓ = D1-MSNs Gangarossa et al., 2013
Apomorphine 3 ↑ ND D1-MSNs Gangarossa et al., 2013
6-OHDA/L-DOPA 20 ↑ ↑ D1-MSNs Santini et al., 2009
20* ↑ ↑ D1-MSNs Santini et al., 2009
10 ↑ ↑ D1-MSNs Santini et al., 2012
Rat Quinelorane 0.16 = ↑ ND Salles et al., 2013
Monkey MPTP/L-DOPA 20 ↑ ND ND Santini et al., 2010
NUCLEUS ACCUMBENS
Mouse Quinelorane 0.63 = ↑ ND Salles et al., 2013
Cocaine 15* ↑ ND ND Sutton and Caron, 2015
Rat Quinelorane 0.16 = ↑ ND Salles et al., 2013
Ketamine 5 ↑ ND ND Tedesco et al., 2013
Cocaine 15 ↑ (NS) ↑ (NS) ND Wu et al., 2011
NMDA 250 (ng) icv ↑ (NS) ↑ (NS) ND Wang et al., 2010
CORTEX
Prefrontal Mouse WAY181187 10 ND ↑ ND Meffre et al., 2012
Rat NMDA 500 (ng) icv ↑ (NS) ↑ (NS) ND Yu et al., 2013
WAY181187 10 ND ↑ ND Meffre et al., 2012
MK801 2 ND ↓ ND Yoon et al., 2008
1* ND ↑ ND Yoon et al., 2008
1* ND ↓ Principal cells Kim et al., 2010
Oubain 1 (mM) icv ↑ ↑ Principal cells Kim et al., 2013
Cingulate MK801 1* ND ↓ Principal cells Kim et al., 2010
Oubain 1 (mM) icv ↑ ↑ Principal cells Kim et al., 2013
Insular MK801 1* ND ↓ Principal cells Kim et al., 2010
Prelimbic Ketamine 5 ↑ ND ND Tedesco et al., 2013
10 ↑ ND ND Tedesco et al., 2013
Infralimbic 5 ↑ ND ND Tedesco et al., 2013
10 ↑ ND ND Tedesco et al., 2013
(Continued)
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TABLE 2 | Continued
Brain
areas
Model Treatment Doses (mg/kg) S235/236 S240/244 Cell-Type References
Somatosensory Kainate 10 ↑ ND pyramidal cells Macias et al., 2013
Piriform ↑ ND ND Macias et al., 2013
NS 12 ND ↑ ND Chen et al., 2012
↑ (NS) ↑ (NS) ND Zeng et al., 2009
Pilocarpine 300 ↑ (NS) ↑ (NS) ND Huang et al., 2010
PTZ 75 ↑ ↑ ND Zhang and Wong, 2012
Cocaine 15 ↑ (NS) ↑ (NS) ND Wu et al., 2011
MK801 0.5 ↓ ↓ ND Kim et al., 2010
1 ↓ ↓ ND Kim et al., 2010
L-phenylalanine 2 (mg/g) ↓ (NS) ↓ (NS) ND Roberts and Morelos, 1979
VENTRAL TEGMENTAL AREA
Mouse Morphine 25 (pellet)* ↑ (NS) ↑ (NS) TH+ cells Mazei-Robison et al., 2011
Rat Cocaine 15 ↑ (NS) ↑ (NS) ND Wu et al., 2011
AMYGDALA
Basolateral Rat Ketamine 10 ↑ ND ND Tedesco et al., 2013
NS Kainate 10 ↑ ND ND Macias et al., 2013
HYPOTHALAMUS
Arcuate Mouse Olanzapine 20 ↑ ND ND Knight et al., 2012
Ghrelin 66 (mg) ↑ ↑ NPY+ cells Knight et al., 2012
6 (mg) icv ND ↑ ND Villanueva et al., 2009
Leptin 5 (mg) icv ND ↑ ND Gong et al., 2007
Insulin 300 (mU/ml) icv ND ↑ ND Villanueva et al., 2009
400 (mU/ml) ND ↑ ND Villanueva et al., 2009
Ventromedial 300 (mU/ml) icv ND ↑ ND Villanueva et al., 2009
Paraventricular Clozapine 10 ↑ ND ND Knight et al., 2012
Rat Leptin 10 (mg) icv ND ↑ ND Cota et al., 2006, 2008
NS CNTFAx15 1.5 (mg) icv ND ↑ ND Cota et al., 2008
C75 30 (mg) icv ND ↑ ND Proulx et al., 2008
Cerulenin 90 (mg) icv ND ↑ ND Proulx et al., 2008
When not specified, a single dose of drug was administered; *repeated doses of drug were administered. NS, not specified; ND, not determined; DG, Dentate Gyrus; MSNs,Medium-sized
Spiny Neurons; THC, tetrahydrocannabinol; PTZ, Pentylenetetrazol; 6-OHDA, 6-hydroxydopamine; L-DOPA, levodopa; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Synaptic Plasticity
Increased rpS6 phosphorylation during synaptic plasticity was
reported for the first time by Klann and colleagues in 1991
using a synthetic peptide of rpS6 containing the residues 222–
249. Since then, enhanced rpS6 phosphorylation has been
observed in several electrical or chemical models of synaptic
plasticity. Thus, pS235/236-rpS6 increases in the CA1 subfield
of the hippocampus during long-term potentiation following
high frequency stimulation (Antion et al., 2008b) or forskolin
application (Kelleher et al., 2004; Antion et al., 2008b; Gobert
et al., 2008). Similarly, mGluR-dependent long-term depression
induced by application of the mGluR1 agonist [3,5-RS]
dihydroxyphenylhydrazine (DHPG) is associated with marked
increases in pS235/236- and pS240/244-rpS6 in hippocampal
slices (Antion et al., 2008a). Interestingly, a recent study reported
that the state of phosphorylation of rpS6 at S240/244 sites
could be used to estimate the neuronal activity state of striatal
cholinergic interneurons (Bertran-Gonzalez et al., 2012).
Pharmacological Stimuli
A large number of pharmacological stimuli have been described
to promote rpS6 phosphorylation in neurons (Tables 1, 2).
Indeed, several ex vivo studies performed in slices or neuronal
cultures showed that rpS6 phosphorylation is enhanced
by stimuli triggering multiple forms of neuronal activity
(Table 1). In vivo, the phosphorylation of rpS6 has been
assessed following a single or repeated administration of
a large variety of pharmacological agents in various brain
areas (Table 2). Thus, proconvulsant drugs such as kainate,
pilocarpine, pentylenetetrazol (PTZ), or the dopamine D1R
agonist SKF81297 lead to a massive increase in pS235/236- and
pS240/244-rpS6 in principal cells in the hippocampus and in
various cortical areas (Table 2). Moreover, the administration
of drugs of abuse (cocaine, d-amphetamine, methamphetamine,
morphine, and tetrahydrocannabinol) as well as antipsychotics
(haloperidol, clozapine, and olanzapine) also regulates rpS6
phosphorylation at multiple sites in several brain areas including
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TABLE 3 | rpS6 phosphorylation regulation under physiological and pathophysiological conditions.
Brain areas Species Model S235/236 S240/244 References
HIPPOCAMPUS
Mouse Contextual FC ↑ ND Kelleher et al., 2004; Saraf et al., 2014
Circadian cycle ↑ ND Saraf et al., 2014
Rat Pilocarpine-induced spontaneous seizure ↑ (NS) ↑ (NS) Huang et al., 2010; Saraf et al., 2014
Kainate-induced spontaneous seizure ↑ ↑ Zeng et al., 2009
Kainate-induced early life seizure = ↑ Bernard et al., 2013
Traumatic brain injury ↑ ND Chen et al., 2007
Human Down syndrome ↑ (NS) ↑ (NS) Iyer et al., 2014
Alzheimer’s disease (severe-stage) ↑ ND Sun et al., 2014
STRIATUM
Mouse Stroke ND ↑ Xiong et al., 2014
NUCLEUS ACCUMBENS
Mouse Highly palatable isocaloric food ↑ ND Guegan et al., 2013
Rat Cue-induced cocaine reinstatement ↑ ND Wang et al., 2010
CORTEX
Prefrontal Mouse Highly palatable isocaloric food ↑ ND Guegan et al., 2013
NS Middle cerebral artery occlusion ND ↑ Xiong et al., 2014
Prefrontal Rat Focal cerebral ischemia ↓ ND Koh, 2013
Neonatal phencyclidine ND ↑ Meffre et al., 2012
Social isolation ND ↑ Meffre et al., 2012
Prelimbic Rat Cue-induced alcohol reinstatement ↑ ND Barak et al., 2013
Extinction after retrieval of FC ↑ ND Tedesco et al., 2014
Infralimbic Extinction after retrieval of FC ↑ ND Tedesco et al., 2014
Orbitofrontal Cue-induced alcohol reinstatement ↑ ND Barak et al., 2013
Parietal Traumatic brain injury ↑ ND Chen et al., 2007
NS Pilocarpine-induced spontaneous seizure ↑ (NS) ↑ (NS) Huang et al., 2010
Kainate-induced spontaneous seizure ↑ (NS) ↑ (NS) Zeng et al., 2009
Cortex Human Focal cortical dysplasia ↑ = Baybis et al., 2004
Focal cortical dysplasia ↑ ND Jansen et al., 2015
Hemimegalencephaly ↑ ND Jansen et al., 2015
Cortical Tubers Tuberous sclerosis (unspecified) ↑ = Baybis et al., 2004
Tuberous sclerosis (specific mutations) ↑ ND Parker et al., 2011
Tuberous sclerosis (TSC1 mutation) ↑ (NS) ↑ (NS) Jansen et al., 2004
Frontal cortex Hemimegalencephaly ↑ ND Aronica et al., 2007
Medial Temporal Cortex Alzheimer’s disease ↑ = An et al., 2003
AMYGDALA
Central Rat Cue-induced alcohol reinstatement ↑ ND Barak et al., 2013
Basolateral Extinction after retrieval of FC ↑ ND Tedesco et al., 2014
HYPOTHALAMUS
Paraventricular Mouse Salt ↑ ↑ Knight et al., 2012
Leucine deprivation ↓ ND Xia et al., 2012
Arcuate Fasting ND ↑ Knight et al., 2012
Fasted ND ↑ Villanueva et al., 2009
Leucine deprivation ↓ ND Xia et al., 2012
Dorsomedial ND ↑ Knight et al., 2012
Preoptic area ND ↑ Knight et al., 2012
Ventrolateral Resident-intruder ↑ ↑ Knight et al., 2012
Premammillary Cat odor ND ↑ Knight et al., 2012
Suprachiasmatic Light ↑ ↑ Cao et al., 2011; Knight et al., 2012
Circadian cycle ND ↑ Cao et al., 2011
Supraoptic Dehydration ND ↑ Knight et al., 2012
(Continued)
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TABLE 3 | Continued
Brain areas Species Model S235/236 S240/244 References
Salt ND ↑ Knight et al., 2012
Arcuate Rat Fasted ND ↓ Cota et al., 2006
PERIAQUEDUCTAL GRAY
Mouse Resident-intruder ↑ ND Knight et al., 2012
SPINAL CORD
Rat Inflammatory pain (carrageenan) ↑ ND Norsted Gregory et al., 2010
Neurogenic inflammation (capsaicin) ↑ ND Géranton et al., 2009
DORSAL ROOT GANGLIA
Rat Inflammatory pain (carrageenan) ↑ ND Norsted Gregory et al., 2010
Neuropathic pain (SNI) ↑ ND Géranton et al., 2009
NS Human Glioblastoma ↑ = Harter et al., 2015
SEGA ↑ ND Chan et al., 2004
NS, not specified; ND, not determined; FC, fear conditioning; SEGA, subependymal giant cell astrocytoma.
the striatum, the nucleus accumbens, the cortex, and the
hippocampus (Table 2). Finally, several hormones involved in
the regulation of energy balance enhance rpS6 phosphorylation
in hypothalamic nuclei (Table 2).
Physiological and Pathophysiological
Conditions
Since the pioneering report demonstrating that rpS6
phosphorylation was enhanced in the CA1 subfield of the
hippocampus in mice trained to contextual fear conditioning
(Kelleher et al., 2004), rpS6 phosphorylation has been used
as a marker of neuronal and circuit activation following
physiological conditions (Table 3). Thus, phospho-rpS6 levels
oscillate in the hippocampus and the suprachiasmatic nucleus
of the hypothalamus along the circadian cycle (Table 3). rpS6
phosphorylation is also strongly modulated in the amygdala
and the hypothalamus when defensive behaviors (freezing,
escape or attacks) are engaged or in the hypothalamus in
response to nutritional perturbations (Table 3). Finally, altered
rpS6 phosphorylation has been reported in rodents following
spontaneous seizures and traumatic brain injury and in humans
in several neurodevelopmental disorders including Down
syndrome, Tuberous sclerosis, Autism, and Rett syndrome
(Table 3).
Genetic Mouse Models Displaying Altered
rpS6 Phosphorylation
Most of the full or conditional knockout mice for the key
components of the mTORC1 pathway display altered rpS6
phosphorylation (Table 4). Interestingly, the vast majority of
mutant mice in which dysregulation of rpS6 phosphorylation
has been demonstrated correspond to mouse models for various
neurological and neurodevelopmental disorders, including
Tuberous sclerosis, Down syndrome, Rett syndrome, Angelman
syndrome, and Fragile X syndrome, among others. Most of these
pathologies share common features such as autism, intellectual
disability, and epilepsy, which might be rescued by mTORC1
inhibitors under certain circumstances. The phosphorylation
of rpS6 is also altered in neurodegenerative diseases such
as Huntington disease and in mouse models of psychiatric
disorders such as schizophrenia (Table 4). Other genetic mouse
models showing hormonal perturbations as leptin deficiency
also display altered rpS6 phosphorylation in the hypothalamus
(Table 4).
PHYSIOLOGICAL ROLE OF rpS6
PHOSPHORYLATION
Role in Overall mRNA Translation
Despite the growing number of reports analyzing the
phosphorylation of rpS6, its biological significance still remains
controversial. One of the first hypotheses put forward suggested
that rpS6 phosphorylation played a role in translation initiation.
Thus, an early in vitro study reported a correlation between the
phosphorylation of rpS6 and enhanced translation under certain
experimental conditions (Thomas et al., 1982). Moreover, the 40S
subunit with a highest proportion of phosphorylated rpS6 was
preferentially found into polysomes compared to subpolysomal
fractions (Duncan and McConkey, 1982). However, several
studies rapidly called into question this hypothesis. Indeed,
although localized at the mRNA/tRNA binding site junction
between the small and large ribosomal subunits (Nygård
and Nilsson, 1990), increased rpS6 phosphorylation is not
sufficient to mobilize small ribosomal subunits into protein
synthesis (Kruppa and Clemens, 1984; Tas and Martini, 1987).
Finally, the generation of rpS6 knockin mice, in which the five
phosphorylated serines were replaced by alanines, constituted
a valuable tool to determine whether rpS6 phosphorylation
and the protein synthesis were causally linked (Ruvinsky et al.,
2005). Unexpectedly, protein synthesis is increased in mouse
embryo fibroblasts (MEF) of phospho-deficient mice. Moreover,
a similar (Ruvinsky et al., 2005) or even increased (Chauvin
et al., 2014) proportion of ribosomes engaged in translation were
found in the liver of rpS6 knockin mice. Together, these puzzling
observations suggest a negative role of rpS6 phosphorylation on
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TABLE 4 | rpS6 phosphorylation in genetic mouse models.
Model Brain area/cell-type S235/236 S240/244 References
KNOCKOUT
Akt3 Whole brain ↓ ↓ Easton et al., 2005
Tsc2+/− Hippocampus ↑ ND Ehninger et al., 2008
Hdc Striatum ↑ = Rapanelli et al., 2014
Fmr1 Hippocampus/pyramidal cells ↑ ↑ Bhattacharya et al., 2012
S6K2 Hippocampus ↓ = Antion et al., 2008a
Mecp2 Cortex/principal cells ↓ ↓ Ricciardi et al., 2011
Cerebellum ↓ ↓ Ricciardi et al., 2011
Hippocampus ↓ = Ricciardi et al., 2011
miR-199a-2 Cortex/principal cells ↓ ND Tsujimura et al., 2015
Hippocampus/pyramidal cells ↓ ND Tsujimura et al., 2015
Cdkl5 Cortex/principal cells ↓ ↓ Amendola et al., 2014
DAT Nucleus accumbens ↑ ND Sutton and Caron, 2015
Lepob/ob Hypothalamus (arcuate) ND ↑ Villanueva et al., 2009
Leprdb/db Hypothalamus (arcuate) ND ↑ Villanueva et al., 2009
CONDITIONAL KNOCKOUT
Tsc1Syn1 Cortex/principal cells ND ↑ Meikle et al., 2007
Hippocampus ND ↑ Meikle et al., 2007
Tsc1GFAP Cortex ↑ ND Parker et al., 2011
Cortex ↑ (NS) ↑ (NS) Zeng et al., 2008, 2011
Hippocampus ↑ (NS) ↑ (NS) Zeng et al., 2008, 2011
Tsc1AAV−CreGFP Hippocampus/pyramidal cells ND ↑ Bateup et al., 2011
Tsc1MCH Hypothalamus ↑ ND Knight et al., 2012
Tsc1L7 Cerebellum/purkinje cells ↑ (NS) ↑ (NS) Tsai et al., 2012
Tsc1Emx1 Cortex/principal cells ↑ ND Magri et al., 2011
Tsc1CaMKII Cortex ↑ ND McMahon et al., 2012
Hippocampus ↑ ND McMahon et al., 2012
Tsc1Temporal# Cortex ND ↑ Feliciano et al., 2011
Tsc2GFAP1 Cortex ↑ (NS) ↑ (NS) Zeng et al., 2011
Hippocampus ↑ (NS) ↑ (NS) Zeng et al., 2011
Tsc2hGFAP Cortex/principal cells ND ↑ Way et al., 2009
Hippocampus/principal cells ND ↑ Way et al., 2009
Tsc2CaMKII Hippocampus/principal cells ND ↑ Rozas et al., 2015
Rheb1Nestin Hypothalamus ↓ ↓ Zou et al., 2011; Yang et al., 2014
Cortex ↓ ↓ Zou et al., 2011
Cerebellum ↓ ↓ Zou et al., 2011
Hippocampus ↓ ↓ Zou et al., 2011
RhebGFAP Hippocampus/granule cells ND ↑ Banerjee et al., 2011
PtenGFAP* Hippocampus/granule cells ↑ ↑ Kwon et al., 2003; Chalhoub et al., 2006;
Lugo et al., 2013
Cerebellum ↑ ND Kwon et al., 2003
PtenGFAP*/S6K1 ko Hippocampus/granule cells ↑ ND Chalhoub et al., 2006
PtenNestin Hippocampus/granule cells ↑ ND Kwon et al., 2006; Zhou et al., 2009
Cortex ↑ ND Zhou et al., 2009
PtenDATCreERT2 Ventral midbrain/DA neurons ↑ ND Domanskyi et al., 2011
RictorNestin Whole brain = ND Thomanetz et al., 2013
Dicer1CaMKCreERT2 Hypothalamus/arcuate nucleus ↑ ND Vinnikov et al., 2014
TARGETED MUTATION
Ube3Atm1Alb/J Cerebellum/purkinje cells ↑ ↑ Sun et al., 2015
Tsc2DRG Hippocampus ↑ = Chévere-Torres et al., 2012
Ts1Cje Hippocampus/principal cells ↑ ND Troca-Marín et al., 2011
(Continued)
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TABLE 4 | Continued
Model Brain area/cell-type S235/236 S240/244 References
N171-N82Q Striatum ↓ ND Ravikumar et al., 2004; Lee et al., 2015
Cortex ↓ ND Ravikumar et al., 2004
Cortex ↓ = Fox et al., 2010
3xTg-AD Whole brain ↑ ND Caccamo et al., 2015
VIRAL-MEDIATED GENE TRANSFER
DISC1-shRNA Hippocampus/granule cells ↑ ND Kim et al., 2009; Zhou et al., 2013
S6K1CA Prefrontal cortex ↑ ND Dwyer et al., 2015
S6K1DN Prefrontal cortex ↑ ND Dwyer et al., 2015
*The Gfap-Cre mice used in these studies lead to Pten deletion in a subset of neuronal cells, including the majority of granule cells in the dentate gyrus and cerebellum. # In utero
electroporation to express Cre recombinase and remove Tsc1 in Tsc1floxed/mutant heterozygous embryos at E16. NS, not specified; ND, not determined; DA, dopaminergic.
global protein synthesis or the presence of feedback mechanisms
taking place in this mouse model.
Role in TOP mRNA Translation
The phosphorylation of rpS6 through the mTORC1/S6K axis
was believed for many years to exert an effect on the
translation of a specific subset of mRNAs bearing a 5′ terminal
oligopyrimidine tract (TOP). However, this long-lasting model
has been challenged by subsequent studies showing that MEFs
from the double mutant S6K1/2 as well as from the rpS6 knockin
mouse lines exhibit normal TOP translation (Tang et al., 2001;
Stolovich et al., 2002; Ruvinsky et al., 2005). Further work
demonstrated that insulin-induced TOP translation requires
the PI3K/TSC/Rheb/mTOR pathway but is independent of the
S6K/rpS6 axis (Patursky-Polischuk et al., 2009).
Despite these evidences, the involvement of rpS6
phosphorylation in the control of translation in the nervous
system is still controversial. Indeed, several findings in
hippocampal neurons and slices correlated increased rpS6
phosphorylation with enhanced global and TOP-encoded
protein synthesis following different forms of synaptic plasticity
(Kelleher et al., 2004; Klann and Dever, 2004; Tsokas et al.,
2005, 2007; Antion et al., 2008a,b) or in a mouse model of
fragile X syndrome (Bhattacharya et al., 2012). By contrast, such
correlations have not been observed in vivo in the striatum where
the pharmacologically-induced rpS6 phosphorylation by d-
amphetamine, haloperidol, or papaverine relies on the activation
of the cAMP/PKA/DARPP-32 pathway (Biever et al., 2015).
Interestingly, the direct binding of mRNA to the small ribosomal
subunit decreases or increases after cAMP-dependent or cAMP-
independent phosphorylation of rpS6, respectively (Burkhard
and Traugh, 1983). Therefore, one cannot exclude that when
an upstream signaling cascade other than PKA is engaged, for
example mTORC1/S6K or ERK/RSK, rpS6 phosphorylation
might have different physiological roles. Nevertheless, despite
compelling studies indicating that rpS6 phosphorylation is
dispensable for efficient global and TOP mRNA translation, the
role of the phosphorylation in the translation of a specific subset
of mRNAs remains to be fully addressed by high-throughput
sequencing analyses of total and polysomal RNAs combined with
proteomic approaches.
Extratranslational Functions
Another possibility is that rpS6 phosphorylation, within or
outside the ribosome, exerts functions unrelated to mRNA
translation, for example by interacting with other cellular
proteins, which might become active or inactive upon the
binding with rpS6. Indeed, co-immunoprecipitation studies
suggest either a direct or indirect interaction of rpS6 with several
extraribosomal proteins, including heat-shock protein 90 (Kim
et al., 2006), alphavirus non-structural protein (Montgomery
et al., 2006), DAPK (Schumacher et al., 2006), huntingtin (Culver
et al., 2012), and mTOR complex 2 (mTORC2) (Yano et al.,
2014). In the latter, rpS6 phosphorylation has been proposed
to have a role in cardioprotective signaling by amplifying
mTORC2-mediated Akt phosphorylation (Yano et al., 2014). In
the mouse liver, Chauvin and colleagues recently uncovered
the involvement of rpS6 phosphorylation in the control of the
ribosome biogenesis (RiBi) transcriptional program by S6Ks
(Chauvin et al., 2014). This program regulates the expression
of nucleolar proteins required for ribosomal RNA synthesis,
cleavage, post-transcriptional modifications, ribosome assembly,
and export (Lempiäinen and Shore, 2009). Whether all these
translation-unrelated responses occur in the brain merits further
study.
Extraribosomal Functions
Surprisingly, extraribosomal functions have been attributed to
several ribosomal proteins (Wool, 1996; Warner and McIntosh,
2009). For instance, the ribosomal protein rpL13a, when
phosphorylated, is released from the 60S ribosomal subunit and
acts as a silencer of targeted mRNAs (Mazumder et al., 2003). In
this regard, few studies suggested an extraribosomal role of rpS6
phosphorylation (Kim et al., 2014; Son et al., 2015; Xiao et al.,
2015). Recent work in the plant Arabidopsis Thaliana proposes
a role of rpS6 in rRNA synthesis and rDNA transcription
via its interaction with the histone deacetylase AtHD2B (Kim
et al., 2014) and the histone chaperon AtNAP1 (Son et al.,
2015), respectively, an effect that might be dependent on the
phosphorylation state of rpS6. Finally, the ubiquitylation and
proteasomal degradation of phosphorylated rpS6 following its
subsequent interaction with PALL has been identified as a critical
mechanism regulating efferocytosis in drosophila (Xiao et al.,
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2015). To date, such extraribosomal functions of rpS6 in the
nervous system have not been described.
CONCLUDING REMARKS
Since the pioneering studies performed four decades ago, many
progresses have been made regarding the identification of
signaling events leading to rpS6 phosphorylation. Although rpS6
phosphorylation is still considered as a readout of mTORC1/S6K
activity, caution should be taken with this assumption since other
intracellular cascades largely contribute to the regulation of rpS6
phosphorylation, as exemplified with the PKA/DARPP-32/PP-1
pathway in the striatum. One should also keep in mind that the
different sites of phosphorylation can be regulated independently
in various brain areas or different cell-types within a same
brain region. Although rpS6 phosphorylation has been and will
remain a valuable hallmark of neuronal activity, understanding
its biological role in the brain is undoubtedly one of the major
challenges of the coming years.
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